Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

NCT04024137 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A

Interventions

DRUG: ZSP1273 200 mg
DRUG: Placebo
DRUG: ZSP1273-400 mg
DRUG: Placebo
DRUG: ZSP1273-600 mg
DRUG: Placebo
DRUG: Placebo

Sponsor

Guangdong Raynovent Biotech Co., Ltd